EMMAUS MEDICAL INC
Biopharmaceutical therapies for rare and orphan diseases
- Sector
- Biotech
- Headquarters
- TORRANCE, CA
- Latest Form D
- $1.2M, May 2011
- Total capital
- $1.2M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $1.2M
- 1 Form D · last May 2011
- 185 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 3
- 10 pending · first 2017
- Rank in peer group#339 of 1449
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$1.2M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1449 peers
Line = medianBiotech · Molecule
- Granted patents#339 · top 23%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Yutaka NiiharaResearcherExecutive Officer, DirectorLinked by 3 patents
- Douglas T. WilmoreDirectorNamed in SEC Form D filings
- Henry T. McKinnel, Jr.DirectorNamed in SEC Form D filings
- Lan T. TranExecutive OfficerNamed in SEC Form D filings
- Willis C. LeeExecutive Officer, DirectorNamed in SEC Form D filings
- Yasushi T. NagasakiExecutive OfficerNamed in SEC Form D filings
What it has protected
USPTO · 3 granted of 13- PendingSystem And Method Of Evaluating Cell CultureUSPTOApplication 18260415
- PendingMethods and compositions for the treatment of diverticulosisUSPTOApplication 17803158
- GrantedMethods and compositions for the treatment of diverticulosisUSPTOUS 11,304,918
Show all 13 patent records
- System And Method Of Evaluating Cell CultureFeb 15, 2024 · Application 18260415Pending
- Methods and compositions for the treatment of diverticulosisJun 30, 2022 · Application 17803158Pending
- Methods and compositions for the treatment of diverticulosisApr 19, 2022 · US 11,304,918Granted
- Methods and compositions for the treatment of sickle cell diseases and thalassemiaJan 21, 2021 · Application 16501994Pending
- Methods and Compositions for the Treatment of Sickle Cell Diseases and ThalassemiaJan 21, 2021 · Application 16873542Pending
- Methods and compositions for the treatment of diverticulosisApr 16, 2019 · US 10,258,586Granted
- Methods and compositions for the treatment of diverticulosisApr 11, 2017 · US 9,616,041Granted
- Methods and compositions for the treatment of diabetes and related symtomsJun 6, 2013 · Application 13694301Pending
- Methods And Compositions For The Treatment Of DiverticulosisApplication PCTUS2012000576Pending
- Methods And Compositions For The Treatment Of Sickle Cell Diseases And ThalassemiaApplication PCTUS2019000033Pending
- Methods And Compositions For The Treatment Of Diabetes And Related SymptomsApplication PCTUS2012000557Pending
- Device and related methods for measuring properties of cell sheets and tissuesApplication 63205757Pending
- System And Method Of Evaluating Cell CultureApplication PCTUS2022011267Pending
Related companies, and why
- Vesselon, Inc.Similar federal contract value in Biotech · null in contracts
- HELUS, INC.Similar federal contract value in Biotech · null in contracts
- Orbsen Therapeutics Ltd.Similar federal contract value in Biotech · null in contracts
- MedGene Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- LevEllis LLCSimilar federal contract value in Biotech · null in contracts
- ICaPath, Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .